MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Genetic, epigenetic and expression profiles in alpha-synucleinopathies

    E. Scott, I. Guella, A. Rajput, A. Rajput, L. Parkkinen, M. Kobor, M. Farrer (Vancouver, BC, Canada)

    Objective: To determine whether each of the alpha-synucleinopathies has distinct methylation and/or expression profiles that distinguishes them from other disorders in this class. Background: The…
  • 2017 International Congress

    Baseline Clinical Predictors of Future Psychotic Symptoms in de novo Parkinson Disease

    M. Barrett, M. Smolkin (Charlottesville, VA, USA)

    Objective: To determine which baseline clinical symptoms are associated with future psychotic symptoms in de novo Parkinson disease (PD). Background: Because psychosis in PD is…
  • 2017 International Congress

    How do Parkinson’s Disease patients manage Ramadan Fasting?

    W. Kamel, P. Damier, J. Al-Hashel (Kuwait, Kuwait)

    Objective: To describe how Parkinson's disease(PD) patients manage Ramadan fasting and the impact of the fasting period on symptoms  Background: Although Ramadan fasting is not…
  • 2017 International Congress

    Rehabilitation program with or without a whey protein-based nutritional support enriched with essential aminoacids and vitamin D in patients with Parkinson’s disease or parkinsonism: study design of a randomized, controlled trial.

    m. barichella, E. Cereda, G. Pinelli, l. Iorio, V. Ferri, g. Frazzitta, E. Cassani, G. Riboldazzi, G. Pezzoli (Milano, Italy)

    Objective: Objective. To evaluate whether the use of a whey protein-based nutritional formula enriched with essential aminoacids – particularly leucine - and vitamin D have…
  • 2017 International Congress

    Self Perception of Dysphagia in Parkinson Disease

    A. Silbergleit, C. Sidiropoulos, R. Konnai, L. Schultz, A. Kitowski, P. LeWitt (West Bloomfield, MI, USA)

    Objective: To determine when individuals with Parkinson disease (PD) perceive impairment of swallowing as it relates to time since diagnosis.  Background: Dysphagia, and particularly silent…
  • 2017 International Congress

    Study Design of an Efficacy and Safety Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of APL-130277 in the Treatment of OFF Episodes (CTH-300)

    C.W. Olanow, E. Pappert, P. Gardzinski, B. Dzyngel, A. Agro (New York, NY, USA)

    Objective: To review the unique features of the ongoing Phase 3 trial for APL-130277.  Background: Patients with Parkinson’s disease (PD) frequently develop problematic OFF episodes…
  • 2017 International Congress

    Effect Of Non-Invasive Vagus Nerve Stimulation In Freezing And Oxidative Stress In Parkinson’s Disease Patients

    B. MONDAL, S. CHOUDHURY, G. PAUL, M. MONDAL, M. BAKER, K. CHATTERJEE, P. CHATTERJEE, R. BANERJEE, R. SINGH, H. KUMAR (KOLKATA, India)

    Objective: In this observational pilot study we explored the long term effect of Non-Invasive VNS to improve the FOG and reduce oxidative stress in PD…
  • 2016 International Congress

    Is inter-limb coupling modified by subthalamic deep brain stimulation and dopaminergic medication in Parkinson’s disease?

    C. Duval, J.F. Daneault, A.F. Sadikot (Montréal, QC, Canada)

    Objective: We characterized different aspects of bimanual coordination in patients with PD, including inter-limb coupling, and then determined whether they were altered by therapeutic modulation…
  • 2016 International Congress

    Deep brain stimulation in the STN of a Parkinsonian rat model overexpressing human A53T α-synuclein in the substantia nigra – A proof of principle

    T. Musacchio, M. Rebenstorff, F. Fluri, C. Kleinschnitz, J.M. Brotchie, J. Volkmann, J.B. Koprich, C.W. Ip (Würzburg, Germany)

    Objective: To determine if subthalamic nucleus (STN)-deep brain stimulation (DBS) leads to a measurable functional improvement of motor deficits in an AAV1/2 A53T α-synuclein (aSyn)…
  • 2016 International Congress

    Is awake intraoperative mapping still necessary for bilateral subthalamic stimulation for Parkinson’s disease in a modern surgical environment?

    Y. Zouitina, M. Lefranc, P. Merle, O. Godefroy, M. Tir, P. Krystkowiak (Amiens, France)

    Objective: To study the impact of the absence of awake clinical evaluation during subthalamic nucleus (STN) deep brain stimulation (DBS) on parameters of stimulation and…
  • « Previous Page
  • 1
  • …
  • 325
  • 326
  • 327
  • 328
  • 329
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley